NCT03375320 2026-04-13Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsNational Cancer Institute (NCI)Phase 3 Active not recruiting298 enrolled 14 charts 3 FDA
NCT02003222 2025-11-28Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting488 enrolled 13 charts 2 FDA